Mereo BioPharma Group plc (MREO): A Bull Case Theory
We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on MREO.
Mereo Biopharma Group Plc (MREO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 15,307,347 | $34,441,531 | 0.62% | |
| 2. | Mangrove Partners Nathaniel August | 8,636,485 | $19,432,091 | 2.1% | |
| 3. | Deerfield Management James E. Flynn | 6,710,429 | $15,098,465 | 0.3% | |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 6,684,247 | $15,039,556 | -31% | 0.86% |
| 5. | Alkeon Capital Management Panayotis Takis Sparaggis | 4,698,100 | $10,570,725 | 0.02% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.22 | 60,046 | $253,454.17 | 808,921 | 2024-09-13 | Filing | |
| $4.47 | 28,611 | $127,968.42 | 868,967 | 2024-09-12 | Filing | |
| $4.22 | 10,937 | $46,165.08 | 78,630 | 2024-09-13 | Filing | |
| $4.47 | 5,212 | $23,311.71 | 89,567 | 2024-09-12 | Filing | |
| $4.22 | 20,946 | $88,413.07 | 219,061 | 2024-09-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,735,121 | $52,404,454 | 0.03% | |
| 2. | 7,819,863 | $17,594,692 | 0.8% | |
| 3. | 2,521,324 | $5,672,979 | 2.19% | |
| 4. | 2,188,354 | $4,923,797 | 0.01% | |
| 5. | 2,179,642 | $4,904,194 | 0% |
News See All
13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
12 Best Biotech Penny Stocks To Invest In Now
Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.
8 Hot Penny Stocks To Invest In According to Hedge Funds
Financial markets are betting that the Federal Reserve's half-point interest rate cut in September will be followed by slower and smaller moves due to the surge in US job growth.
Mereo BioPharma Group plc (MREO): A Bull Case Theory
We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Raging Bull Investments’ Substack by Jake LaMotta. In this article we will summarize the bulls’ thesis on MREO.
15 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the 15 top performing European stocks so far in 2024.
Hedge Funds Say These Penny Stocks Are Poised to Explode
Despite common belief, not all penny stocks are inherently risky and suitable only for short-term gains.
Chinese Billionaire Zhang Lei is Selling These 10 Stocks
In this article, we present the list of the 1o stocks that billionaire Zhang Lei is selling off.
Do Hedge Funds Love Mereo BioPharma Group plc (MREO)?
In this article you are going to find out whether hedge funds think Mereo BioPharma Group plc (NASDAQ:MREO) is a good investment right now.
5 Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we will discuss 5 micro-cap stocks to buy according to hedge funds.